Cite
HARVARD Citation
Toft, A. et al. (2018). Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan. Cancer investigation. pp. 165-174. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Toft, A. et al. (2018). Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan. Cancer investigation. pp. 165-174. [Online].